You can tell analysts took the last couple of weeks off with the flood of notes we got this morning -- here’s everything that caught my eye 🧐
1. $Palantir Technologies Inc.(PLTR)$
• AI-driven software pioneer trading at 56x EV/NTM Sales, with growth led by its Government segment. Analysts caution that commercial revenue lags expectations, and valuation is pricing in a 30% 10-year CAGR -- resulting in an Underweight rating and a $60 price target.
2. $Hims & Hers Health Inc.(HIMS)$
• Emerging leader in digital health, trading at 3x FY25 revenue with multiple growth levers, including personalized products and expanding weight-loss solutions. Analysts highlight a compelling entry point amid FDA-related volatility and expect HIMS to achieve the Rule of 50 -- driving a $31 price target.
3. $TransMedics Group, Inc.(TMDX)$
• Revolutionizing organ transplant logistics with a record Q4 flight count supporting service revenues. Machine perfusion adoption offsets transplant volume weakness -- with analysts projecting strong growth in 2025 and maintaining a $90 price target.
• High-quality database franchise approaching a $4B run-rate with a 25%+ FCF margin model. CIO survey data supports increasing enterprise investments in core and AI/ML workloads, reinforcing demand stabilization. A product-first approach under new leadership could drive further upside in 2025. Analysts raised the price target to $208 -- citing higher estimates and favorable CIO spending intentions.
• Dominating CRM software with an 8.6x EV/NTM revenue multiple, but growth is slowing. Analysts see limited innovation and talent retention challenges, with FY26 growth estimates revised to 5–7%. Despite its strong position as a system of record -- the company’s AI monetization strategy remains uncertain, leading to a $247 price target.
• Cloud database leader with a $300 price target, up 22% from current levels. Stable Atlas consumption trends and a hybrid strategy are expected to sustain low-teen growth -- positioning MongoDB to capture AI-driven workloads and expand its TAM.
7. $Block(SQ)$
• Named a 2025 Top Pick, with Seller GPV growth expected to accelerate into double digits in 2025. Analysts see upside from easing comps, international expansion, and product innovation. While Cash App remains a wild card, engagement efforts are expected to support gross profit. Trading at a 15% discount to peers -- $SQ is viewed as attractively valued with a $115 price target.
• Cybersecurity powerhouse facing declining new ARR for five consecutive quarters, despite a strong stock performance. With Federal IT spending moderating and adjusted FCF margins at 25–26%, the company’s valuation appears stretched -- leading to a $130 price target and a downgrade to Sell.
• Cybersecurity leader benefiting from a new firewall cycle and increasing software mix. Recent innovations and acquisitions strengthen its market position -- with analysts upgrading to Overweight and setting a $120 price target.
• Fast-growing specialty coffee chain, up 61% since its Q4 report. Analysts expect continued outperformance in 2025, supported by strong operating momentum and long-term growth prospects -- justifying a $70 price target.
Comments
Great article, would you like to share it?